SEI Investments’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-5,268
Closed -$95K 3840
2017
Q4
$95K Sell
5,268
-2,532
-32% -$31.2K ﹤0.01% 2163
2017
Q3
$92K Buy
7,800
+2,835
+57% +$31.8K ﹤0.01% 2102
2017
Q2
$53K Buy
4,965
+1,817
+58% +$18.5K ﹤0.01% 2232
2017
Q1
$35K Buy
3,148
+1,525
+94% +$17.7K ﹤0.01% 2219
2016
Q4
$22K Buy
+1,623
New +$22.6K ﹤0.01% 2324
2016
Q3
Sell
-2
Closed 3066
2016
Q2
$0 Sell
2
-66
-97% -$739 ﹤0.01% 2830
2016
Q1
$1K Buy
68
+36
+113% +$455 ﹤0.01% 2474
2015
Q4
$1K Sell
32
-8,514
-100% -$153K ﹤0.01% 2489
2015
Q3
$170K Buy
+8,546
New +$196K ﹤0.01% 1650

Other funds holding SCMP

SEI Investments's SCMP Position: Q1 2018 in Review

SEI Investments sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 5,268 shares — an estimated $95K sold.

SEI Investments first reported a position in SCMP in Q3 2015 and held it in 9 quarters. The position peaked at $170K in Q3 2015. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

  • SEI Investments reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
  • SEI Investments sold 5,268 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $95K.
  • SEI Investments first reported a position in Sucampo Pharmaceuticals, Inc. in Q3 2015 and held it in 9 quarters.
  • SEI Investments's Sucampo Pharmaceuticals, Inc. position peaked at $170K in Q3 2015.
  • 3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.

Based on SEI Investments's 13F filing for Q1 2018, filed 11 May 2018.